25 XP   0   0   10

Givaudan SA ADR
Buy, Hold or Sell?

Let's analyse Givaudan together

PenkeI guess you are interested in Givaudan SA ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Givaudan SA ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Givaudan SA ADR

I send you an email if I find something interesting about Givaudan SA ADR.

Quick analysis of Givaudan (30 sec.)










What can you expect buying and holding a share of Givaudan? (30 sec.)

How much money do you get?

How much money do you get?
$1.34
When do you have the money?
1 year
How often do you get paid?
78.6%

What is your share worth?

Current worth
$8.67
Expected worth in 1 year
$8.15
How sure are you?
78.6%

+ What do you gain per year?

Total Gains per Share
$0.82
Return On Investment
0.9%

For what price can you sell your share?

Current Price per Share
$92.32
Expected price per share
$88.51 - $
How sure are you?
50%

1. Valuation of Givaudan (5 min.)




Live pricePrice per Share (EOD)

$92.32

2. Growth of Givaudan (5 min.)




Is Givaudan growing?

Current yearPrevious yearGrowGrow %
How rich?$3.9b$4.1b-$137m-3.4%

How much money is Givaudan making?

Current yearPrevious yearGrowGrow %
Making money$366.6m$346.2m$20.4m5.6%
Net Profit Margin12.9%9.0%--

How much money comes from the company's main activities?

3. Financial Health of Givaudan (5 min.)




4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  


Richest
#38 / 560

Most Revenue
#7 / 560

Most Profit
#5 / 560

What can you expect buying and holding a share of Givaudan? (5 min.)

Welcome investor! Givaudan's management wants to use your money to grow the business. In return you get a share of Givaudan.

What can you expect buying and holding a share of Givaudan?

First you should know what it really means to hold a share of Givaudan. And how you can make/lose money.

Speculation

The Price per Share of Givaudan is $92.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Givaudan.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Givaudan, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.67. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.33 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Givaudan.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.051.1%0.790.9%0.510.6%0.530.6%0.470.5%
Usd Book Value Change Per Share0.000.0%-0.13-0.1%0.160.2%0.030.0%0.310.3%
Usd Dividend Per Share0.000.0%0.330.4%0.330.4%0.450.5%0.450.5%
Usd Total Gains Per Share0.000.0%0.200.2%0.490.5%0.480.5%0.760.8%
Usd Price Per Share82.79-69.90-68.89-72.77-64.56-
Price to Earnings Ratio19.64-24.20-33.84-37.22-48.84-
Price-to-Total Gains Ratio798.60-113.71-189.50-144.74-
Price to Book Ratio9.55-8.12-7.77-9.07-9.62-
Price-to-Total Gains Ratio798.60-113.71-189.50-144.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share92.32
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.330.45
Usd Book Value Change Per Share-0.130.03
Usd Total Gains Per Share0.200.48
Gains per Quarter (10 shares)2.054.78
Gains per Year (10 shares)8.1919.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
113-5-21819
227-10636228
340-161454447
453-212272566
567-263090685
680-31381077104
794-36461258123
8107-415414310142
9120-476216111161
10134-527017912180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%28.00.00.0100.0%28.00.00.0100.0%
Book Value Change Per Share1.01.02.025.0%5.01.06.041.7%7.03.010.035.0%10.05.013.035.7%10.05.013.035.7%
Dividend per Share2.00.02.050.0%8.00.04.066.7%14.00.06.070.0%22.00.06.078.6%22.00.06.078.6%
Total Gains per Share3.00.01.075.0%10.00.02.083.3%15.02.03.075.0%22.03.03.078.6%22.03.03.078.6%

Fundamentals of Givaudan

About Givaudan SA ADR

Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, alcoholic beverages, and others; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.

Fundamental data was last updated by Penke on 2024-05-17 00:33:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Givaudan SA ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Givaudan earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Givaudan to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 13.1% means that $0.13 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Givaudan SA ADR:

  • The MRQ is 13.1%. The company is making a huge profit. +2
  • The TTM is 12.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.1%TTM12.9%+0.2%
TTM12.9%YOY9.0%+3.9%
TTM12.9%5Y6.7%+6.3%
5Y6.7%10Y8.5%-1.9%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ13.1%4.0%+9.1%
TTM12.9%3.8%+9.1%
YOY9.0%5.2%+3.8%
5Y6.7%5.8%+0.9%
10Y8.5%5.8%+2.7%
1.1.2. Return on Assets

Shows how efficient Givaudan is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Givaudan to the Specialty Chemicals industry mean.
  • 4.4% Return on Assets means that Givaudan generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Givaudan SA ADR:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM3.2%+1.1%
TTM3.2%YOY3.0%+0.3%
TTM3.2%5Y2.3%+0.9%
5Y2.3%10Y2.3%+0.0%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%1.0%+3.4%
TTM3.2%1.0%+2.2%
YOY3.0%1.4%+1.6%
5Y2.3%1.4%+0.9%
10Y2.3%1.6%+0.7%
1.1.3. Return on Equity

Shows how efficient Givaudan is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Givaudan to the Specialty Chemicals industry mean.
  • 12.2% Return on Equity means Givaudan generated $0.12 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Givaudan SA ADR:

  • The MRQ is 12.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 9.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.2%TTM9.2%+2.9%
TTM9.2%YOY8.4%+0.8%
TTM9.2%5Y6.9%+2.4%
5Y6.9%10Y6.3%+0.5%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ12.2%1.9%+10.3%
TTM9.2%1.8%+7.4%
YOY8.4%2.6%+5.8%
5Y6.9%2.6%+4.3%
10Y6.3%2.7%+3.6%

1.2. Operating Efficiency of Givaudan SA ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Givaudan is operating .

  • Measures how much profit Givaudan makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Givaudan to the Specialty Chemicals industry mean.
  • An Operating Margin of 15.8% means the company generated $0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Givaudan SA ADR:

  • The MRQ is 15.8%. The company is operating efficient. +1
  • The TTM is 16.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ15.8%TTM16.1%-0.3%
TTM16.1%YOY11.1%+5.0%
TTM16.1%5Y8.4%+7.7%
5Y8.4%10Y10.6%-2.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ15.8%8.0%+7.8%
TTM16.1%3.4%+12.7%
YOY11.1%6.8%+4.3%
5Y8.4%7.5%+0.9%
10Y10.6%7.2%+3.4%
1.2.2. Operating Ratio

Measures how efficient Givaudan is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are $0.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Givaudan SA ADR:

  • The MRQ is 0.842. The company is less efficient in keeping operating costs low.
  • The TTM is 0.840. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.842TTM0.840+0.002
TTM0.840YOY0.640+0.200
TTM0.8405Y0.585+0.256
5Y0.58510Y0.819-0.234
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8421.547-0.705
TTM0.8401.542-0.702
YOY0.6401.476-0.836
5Y0.5851.459-0.874
10Y0.8191.239-0.420

1.3. Liquidity of Givaudan SA ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Givaudan is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 1.75 means the company has $1.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Givaudan SA ADR:

  • The MRQ is 1.754. The company is able to pay all its short-term debts. +1
  • The TTM is 1.525. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.754TTM1.525+0.229
TTM1.525YOY1.638-0.113
TTM1.5255Y1.591-0.066
5Y1.59110Y1.654-0.063
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7541.835-0.081
TTM1.5251.892-0.367
YOY1.6381.907-0.269
5Y1.5911.920-0.329
10Y1.6541.772-0.118
1.3.2. Quick Ratio

Measures if Givaudan is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Givaudan to the Specialty Chemicals industry mean.
  • A Quick Ratio of 1.03 means the company can pay off $1.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Givaudan SA ADR:

  • The MRQ is 1.033. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.852. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.033TTM0.852+0.180
TTM0.852YOY0.896-0.044
TTM0.8525Y0.858-0.006
5Y0.85810Y0.901-0.043
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0330.787+0.246
TTM0.8520.840+0.012
YOY0.8960.952-0.056
5Y0.8581.049-0.191
10Y0.9011.046-0.145

1.4. Solvency of Givaudan SA ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Givaudan assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Givaudan to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.64 means that Givaudan assets are financed with 64.1% credit (debt) and the remaining percentage (100% - 64.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Givaudan SA ADR:

  • The MRQ is 0.641. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.650. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.641TTM0.650-0.009
TTM0.650YOY0.645+0.004
TTM0.6505Y0.660-0.011
5Y0.66010Y0.631+0.030
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6410.425+0.216
TTM0.6500.431+0.219
YOY0.6450.420+0.225
5Y0.6600.431+0.229
10Y0.6310.439+0.192
1.4.2. Debt to Equity Ratio

Measures if Givaudan is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Givaudan to the Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 178.6% means that company has $1.79 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Givaudan SA ADR:

  • The MRQ is 1.786. The company is just able to pay all its debts with equity.
  • The TTM is 1.860. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.786TTM1.860-0.074
TTM1.860YOY1.826+0.033
TTM1.8605Y1.963-0.103
5Y1.96310Y1.764+0.199
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7860.760+1.026
TTM1.8600.769+1.091
YOY1.8260.729+1.097
5Y1.9630.811+1.152
10Y1.7640.844+0.920

2. Market Valuation of Givaudan SA ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Givaudan generates.

  • Above 15 is considered overpriced but always compare Givaudan to the Specialty Chemicals industry mean.
  • A PE ratio of 19.64 means the investor is paying $19.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Givaudan SA ADR:

  • The EOD is 21.906. Based on the earnings, the company is fair priced.
  • The MRQ is 19.645. Based on the earnings, the company is fair priced.
  • The TTM is 24.201. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD21.906MRQ19.645+2.261
MRQ19.645TTM24.201-4.557
TTM24.201YOY33.835-9.634
TTM24.2015Y37.223-13.022
5Y37.22310Y48.845-11.621
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD21.90617.220+4.686
MRQ19.64515.871+3.774
TTM24.20116.169+8.032
YOY33.83516.181+17.654
5Y37.22319.640+17.583
10Y48.84524.869+23.976
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Givaudan SA ADR:

  • The EOD is 10.368. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.298. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -34.506. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.368MRQ9.298+1.070
MRQ9.298TTM-34.506+43.804
TTM-34.506YOY-24.506-10.001
TTM-34.5065Y-11.802-22.704
5Y-11.80210Y-8.430-3.372
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD10.368-1.128+11.496
MRQ9.298-1.428+10.726
TTM-34.5062.909-37.415
YOY-24.5060.068-24.574
5Y-11.8022.849-14.651
10Y-8.4302.912-11.342
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Givaudan is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 9.55 means the investor is paying $9.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Givaudan SA ADR:

  • The EOD is 10.654. Based on the equity, the company is expensive. -2
  • The MRQ is 9.554. Based on the equity, the company is overpriced. -1
  • The TTM is 8.117. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.654MRQ9.554+1.100
MRQ9.554TTM8.117+1.437
TTM8.117YOY7.774+0.343
TTM8.1175Y9.068-0.951
5Y9.06810Y9.617-0.549
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD10.6541.842+8.812
MRQ9.5541.698+7.856
TTM8.1171.773+6.344
YOY7.7742.136+5.638
5Y9.0682.324+6.744
10Y9.6172.729+6.888
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Givaudan SA ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.1300%0.160-100%0.030-100%0.309-100%
Book Value Per Share--8.6668.609+1%8.906-3%8.088+7%7.667+13%
Current Ratio--1.7541.525+15%1.638+7%1.591+10%1.654+6%
Debt To Asset Ratio--0.6410.650-1%0.645-1%0.660-3%0.631+2%
Debt To Equity Ratio--1.7861.860-4%1.826-2%1.963-9%1.764+1%
Dividend Per Share---0.334-100%0.329-100%0.448-100%0.449-100%
Eps--1.0540.795+33%0.508+107%0.529+99%0.470+124%
Free Cash Flow Per Share--2.2260.861+159%0.685+225%0.786+183%0.786+183%
Free Cash Flow To Equity Per Share--1.2610.345+265%0.360+251%0.352+259%0.352+259%
Gross Profit Margin--0.4950.247+101%0.460+8%0.741-33%0.815-39%
Market Cap42592938362.880+10%38196158655.36032251163470.032+18%31783919120.736+20%33575549181.302+14%29786814909.710+28%
Net Profit Margin--0.1310.129+2%0.090+46%0.067+98%0.085+54%
Operating Margin--0.1580.161-2%0.111+43%0.084+88%0.106+49%
Operating Ratio--0.8420.840+0%0.640+31%0.585+44%0.819+3%
Pb Ratio10.654+10%9.5548.117+18%7.774+23%9.068+5%9.617-1%
Pe Ratio21.906+10%19.64524.201-19%33.835-42%37.223-47%48.845-60%
Price Per Share92.320+10%82.79069.904+18%68.892+20%72.775+14%64.563+28%
Price To Free Cash Flow Ratio10.368+10%9.298-34.506+471%-24.506+364%-11.802+227%-8.430+191%
Quick Ratio--1.0330.852+21%0.896+15%0.858+20%0.901+15%
Return On Assets--0.0440.032+35%0.030+47%0.023+87%0.023+90%
Return On Equity--0.1220.092+32%0.084+44%0.069+77%0.063+92%
Total Gains Per Share---0.205-100%0.489-100%0.478-100%0.758-100%
Usd Book Value--3998000000.0003972000000.000+1%4109000000.000-3%3731700000.000+7%3537465801.258+13%
Usd Book Value Change Per Share----0.1300%0.160-100%0.030-100%0.309-100%
Usd Book Value Per Share--8.6668.609+1%8.906-3%8.088+7%7.667+13%
Usd Dividend Per Share---0.334-100%0.329-100%0.448-100%0.449-100%
Usd Eps--1.0540.795+33%0.508+107%0.529+99%0.470+124%
Usd Free Cash Flow--1027000000.000397250000.000+159%237125000.000+333%126875000.000+709%90625000.000+1033%
Usd Free Cash Flow Per Share--2.2260.861+159%0.685+225%0.786+183%0.786+183%
Usd Free Cash Flow To Equity Per Share--1.2610.345+265%0.360+251%0.352+259%0.352+259%
Usd Market Cap42592938362.880+10%38196158655.36032251163470.032+18%31783919120.736+20%33575549181.302+14%29786814909.710+28%
Usd Price Per Share92.320+10%82.79069.904+18%68.892+20%72.775+14%64.563+28%
Usd Profit--486091200.000366621150.000+33%346216800.000+40%259195070.000+88%227681850.051+113%
Usd Revenue--3700424000.0002838953250.000+30%2422108150.000+53%1391764500.000+166%1319573866.715+180%
Usd Total Gains Per Share---0.205-100%0.489-100%0.478-100%0.758-100%
 EOD+3 -4MRQTTM+24 -9YOY+22 -135Y+24 -1110Y+23 -12

3.2. Fundamental Score

Let's check the fundamental score of Givaudan SA ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1521.906
Price to Book Ratio (EOD)Between0-110.654
Net Profit Margin (MRQ)Greater than00.131
Operating Margin (MRQ)Greater than00.158
Quick Ratio (MRQ)Greater than11.033
Current Ratio (MRQ)Greater than11.754
Debt to Asset Ratio (MRQ)Less than10.641
Debt to Equity Ratio (MRQ)Less than11.786
Return on Equity (MRQ)Greater than0.150.122
Return on Assets (MRQ)Greater than0.050.044
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Givaudan SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.956
Ma 20Greater thanMa 5089.961
Ma 50Greater thanMa 10088.740
Ma 100Greater thanMa 20085.233
OpenGreater thanClose92.690
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  425,00097,000522,000-119,000403,00090,000493,000-3,420,000-2,927,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets11,128,000
Total Liabilities7,130,000
Total Stockholder Equity3,993,000
 As reported
Total Liabilities 7,130,000
Total Stockholder Equity+ 3,993,000
Total Assets = 11,128,000

Assets

Total Assets11,128,000
Total Current Assets3,615,000
Long-term Assets7,513,000
Total Current Assets
Cash And Cash Equivalents 600,000
Short-term Investments 8,000
Net Receivables 1,512,000
Inventory 1,275,000
Other Current Assets 220,000
Total Current Assets  (as reported)3,615,000
Total Current Assets  (calculated)3,615,000
+/-0
Long-term Assets
Property Plant Equipment 2,242,000
Goodwill 3,203,000
Intangible Assets 4,459,000
Long-term Assets Other -2,927,000
Long-term Assets  (as reported)7,513,000
Long-term Assets  (calculated)6,977,000
+/- 536,000

Liabilities & Shareholders' Equity

Total Current Liabilities2,061,000
Long-term Liabilities5,069,000
Total Stockholder Equity3,993,000
Total Current Liabilities
Short-term Debt 442,000
Short Long Term Debt 397,000
Accounts payable 891,000
Other Current Liabilities 592,000
Total Current Liabilities  (as reported)2,061,000
Total Current Liabilities  (calculated)2,322,000
+/- 261,000
Long-term Liabilities
Long term Debt 4,101,000
Capital Lease Obligations 407,000
Long-term Liabilities Other 107,000
Long-term Liabilities  (as reported)5,069,000
Long-term Liabilities  (calculated)4,615,000
+/- 454,000
Total Stockholder Equity
Common Stock92,000
Retained Earnings 6,730,000
Accumulated Other Comprehensive Income -2,630,000
Other Stockholders Equity -199,000
Total Stockholder Equity (as reported)3,993,000
Total Stockholder Equity (calculated)3,993,000
+/-0
Other
Capital Stock92,000
Cash and Short Term Investments 608,000
Common Stock Shares Outstanding 9,260
Current Deferred Revenue136,000
Liabilities and Stockholders Equity 11,128,000
Net Debt 4,305,000
Net Invested Capital 8,491,000
Net Working Capital 1,554,000
Property Plant and Equipment Gross 4,519,000
Short Long Term Debt Total 4,905,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-06-302015-12-312015-06-302014-12-312014-06-302013-12-312013-06-302012-12-312012-06-302011-12-312011-06-302010-12-312010-06-302009-12-31
> Total Assets 
7,083,000
7,055,000
6,923,000
6,798,000
6,716,000
6,471,000
6,350,000
6,383,000
6,202,000
6,151,000
6,472,000
5,920,000
6,282,000
6,159,000
6,514,000
6,617,000
6,617,000
894,603
7,309,000
8,056,000
8,056,000
9,268,000
9,268,000
9,764,000
9,764,000
10,396,000
10,396,000
0
10,915,000
0
10,658,000
0
11,342,000
0
11,420,000
0
11,914,000
11,509,000
11,509,000
11,566,000
11,566,000
11,128,000
11,128,000
11,128,00011,128,00011,566,00011,566,00011,509,00011,509,00011,914,000011,420,000011,342,000010,658,000010,915,000010,396,00010,396,0009,764,0009,764,0009,268,0009,268,0008,056,0008,056,0007,309,000894,6036,617,0006,617,0006,514,0006,159,0006,282,0005,920,0006,472,0006,151,0006,202,0006,383,0006,350,0006,471,0006,716,0006,798,0006,923,0007,055,0007,083,000
   > Total Current Assets 
2,389,000
2,411,000
2,609,000
2,712,000
2,469,000
2,225,000
2,195,000
2,397,000
2,301,000
2,275,000
2,357,000
2,140,000
2,279,000
2,278,000
2,343,000
2,428,000
2,428,000
349,323
2,854,000
3,368,000
3,368,000
3,121,000
3,121,000
3,209,000
3,209,000
3,242,000
3,242,000
3,512,000
3,512,000
3,299,000
3,299,000
3,606,000
3,606,000
3,406,000
3,406,000
3,942,000
3,942,000
3,707,000
3,707,000
3,747,000
3,747,000
3,615,000
3,615,000
3,615,0003,615,0003,747,0003,747,0003,707,0003,707,0003,942,0003,942,0003,406,0003,406,0003,606,0003,606,0003,299,0003,299,0003,512,0003,512,0003,242,0003,242,0003,209,0003,209,0003,121,0003,121,0003,368,0003,368,0002,854,000349,3232,428,0002,428,0002,343,0002,278,0002,279,0002,140,0002,357,0002,275,0002,301,0002,397,0002,195,0002,225,0002,469,0002,712,0002,609,0002,411,0002,389,000
       Cash And Cash Equivalents 
825,000
486,000
805,000
823,000
545,000
240,000
368,000
385,000
513,000
293,000
412,000
216,000
478,000
260,000
328,000
220,000
220,000
65,360
534,000
231,000
231,000
423,000
423,000
239,000
239,000
452,000
452,000
0
432,000
0
411,000
0
306,000
0
273,000
0
310,000
475,000
475,000
244,000
244,000
600,000
600,000
600,000600,000244,000244,000475,000475,000310,0000273,0000306,0000411,0000432,0000452,000452,000239,000239,000423,000423,000231,000231,000534,00065,360220,000220,000328,000260,000478,000216,000412,000293,000513,000385,000368,000240,000545,000823,000805,000486,000825,000
       Short-term Investments 
18,000
48,000
54,000
63,000
54,000
55,000
-143,000
-6,000
-11,000
-12,000
-7,000
-12,000
-15,000
1,000
1,000
0
-29,000
0
2,000
0
612,000
0
4,000
0
3,000
0
4,000
0
4,000
0
4,000
0
4,000
0
4,000
0
13,000
13,000
13,000
6,000
6,000
8,000
8,000
8,0008,0006,0006,00013,00013,00013,00004,00004,00004,00004,00004,00003,00004,0000612,00002,0000-29,00001,0001,000-15,000-12,000-7,000-12,000-11,000-6,000-143,00055,00054,00063,00054,00048,00018,000
       Net Receivables 
819,000
929,000
888,000
869,000
901,000
939,000
955,000
1,063,000
968,000
1,017,000
1,028,000
1,027,000
942,000
1,065,000
1,034,000
1,296,000
1,137,000
156,302
1,318,000
1,377,000
1,334,000
1,532,000
1,358,000
1,615,000
1,510,000
1,578,000
1,474,000
1,659,000
1,605,000
1,579,000
1,529,000
1,812,000
1,714,000
1,668,000
1,602,000
1,911,000
1,883,000
1,512,000
1,668,000
1,650,000
1,808,000
1,452,000
1,512,000
1,512,0001,452,0001,808,0001,650,0001,668,0001,512,0001,883,0001,911,0001,602,0001,668,0001,714,0001,812,0001,529,0001,579,0001,605,0001,659,0001,474,0001,578,0001,510,0001,615,0001,358,0001,532,0001,334,0001,377,0001,318,000156,3021,137,0001,296,0001,034,0001,065,000942,0001,027,0001,028,0001,017,000968,0001,063,000955,000939,000901,000869,000888,000929,000819,000
       Inventory 
633,000
727,000
735,000
797,000
839,000
825,000
725,000
751,000
692,000
745,000
771,000
732,000
716,000
761,000
788,000
886,000
886,000
110,403
902,000
1,075,000
1,075,000
1,098,000
1,098,000
1,278,000
1,278,000
1,149,000
1,149,000
1,336,000
1,336,000
1,201,000
1,201,000
1,396,000
1,396,000
1,380,000
1,380,000
1,585,000
1,585,000
1,423,000
1,423,000
1,541,000
1,541,000
1,275,000
1,275,000
1,275,0001,275,0001,541,0001,541,0001,423,0001,423,0001,585,0001,585,0001,380,0001,380,0001,396,0001,396,0001,201,0001,201,0001,336,0001,336,0001,149,0001,149,0001,278,0001,278,0001,098,0001,098,0001,075,0001,075,000902,000110,403886,000886,000788,000761,000716,000732,000771,000745,000692,000751,000725,000825,000839,000797,000735,000727,000633,000
       Other Current Assets 
94,000
221,000
127,000
160,000
130,000
166,000
147,000
198,000
128,000
220,000
146,000
165,000
143,000
191,000
192,000
26,000
185,000
1,958
98,000
12,000
116,000
11,000
238,000
8,000
179,000
24,000
163,000
32,000
135,000
54,000
154,000
23,000
186,000
16,000
147,000
28,000
151,000
297,000
128,000
312,000
148,000
288,000
220,000
220,000288,000148,000312,000128,000297,000151,00028,000147,00016,000186,00023,000154,00054,000135,00032,000163,00024,000179,0008,000238,00011,000116,00012,00098,0001,958185,00026,000192,000191,000143,000165,000146,000220,000128,000198,000147,000166,000130,000160,000127,000221,00094,000
   > Long-term Assets 
4,694,000
4,644,000
4,314,000
4,086,000
4,247,000
4,246,000
4,155,000
3,986,000
3,901,000
3,876,000
4,115,000
3,780,000
4,003,000
3,881,000
4,171,000
0
4,189,000
0
4,455,000
0
4,688,000
0
6,147,000
0
6,555,000
0
7,154,000
0
7,403,000
0
7,359,000
0
7,736,000
0
8,014,000
0
7,972,000
7,802,000
7,802,000
7,819,000
7,819,000
7,513,000
7,513,000
7,513,0007,513,0007,819,0007,819,0007,802,0007,802,0007,972,00008,014,00007,736,00007,359,00007,403,00007,154,00006,555,00006,147,00004,688,00004,455,00004,189,00004,171,0003,881,0004,003,0003,780,0004,115,0003,876,0003,901,0003,986,0004,155,0004,246,0004,247,0004,086,0004,314,0004,644,0004,694,000
       Property Plant Equipment 
1,437,000
1,388,000
1,312,000
1,264,000
1,366,000
1,372,000
1,388,000
1,373,000
1,355,000
1,328,000
1,430,000
1,327,000
1,384,000
1,357,000
1,442,000
1,431,000
1,431,000
193,266
1,579,000
1,611,000
1,611,000
1,759,000
1,759,000
2,183,000
2,183,000
2,326,000
2,326,000
2,229,000
2,229,000
2,222,000
2,222,000
2,260,000
2,260,000
2,291,000
2,291,000
2,307,000
2,307,000
2,293,000
2,293,000
2,254,000
2,254,000
2,242,000
2,242,000
2,242,0002,242,0002,254,0002,254,0002,293,0002,293,0002,307,0002,307,0002,291,0002,291,0002,260,0002,260,0002,222,0002,222,0002,229,0002,229,0002,326,0002,326,0002,183,0002,183,0001,759,0001,759,0001,611,0001,611,0001,579,000193,2661,431,0001,431,0001,442,0001,357,0001,384,0001,327,0001,430,0001,328,0001,355,0001,373,0001,388,0001,372,0001,366,0001,264,0001,312,0001,388,0001,437,000
       Goodwill 
0
0
0
0
0
0
1,688,000
0
1,616,000
0
1,718,000
0
1,707,000
0
1,791,000
0
0
234,024
1,912,000
0
0
2,959,000
2,959,000
0
0
3,146,000
3,146,000
0
0
0
3,294,000
0
0
0
3,496,000
0
0
3,423,000
3,423,000
0
0
3,203,000
3,203,000
3,203,0003,203,000003,423,0003,423,000003,496,0000003,294,0000003,146,0003,146,000002,959,0002,959,000001,912,000234,024001,791,00001,707,00001,718,00001,616,00001,688,000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92,000
92,000
11,750
11,703
103,000
103,000
94,000
94,000
101,000
101,000
211,000
211,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000211,000211,000101,000101,00094,00094,000103,000103,00011,70311,75092,00092,000000000000000000
       Intangible Assets 
0
2,950,000
0
2,523,000
0
0
767,000
0
656,000
0
575,000
0
490,000
0
520,000
2,334,000
2,334,000
69,767
570,000
2,694,000
2,694,000
1,040,000
1,040,000
3,960,000
3,960,000
1,140,000
1,140,000
0
0
0
1,249,000
0
0
0
1,357,000
0
4,796,000
1,223,000
1,223,000
4,716,000
4,716,000
1,256,000
4,459,000
4,459,0001,256,0004,716,0004,716,0001,223,0001,223,0004,796,00001,357,0000001,249,0000001,140,0001,140,0003,960,0003,960,0001,040,0001,040,0002,694,0002,694,000570,00069,7672,334,0002,334,000520,0000490,0000575,0000656,0000767,000002,523,00002,950,0000
       Long-term Assets Other 
208,000
252,000
233,000
237,000
248,000
255,000
69,000
69,000
65,000
64,000
75,000
70,000
85,000
64,000
66,000
0
52,000
0
93,000
0
700,000
0
91,000
0
94,000
0
124,000
0
104,000
0
165,000
0
329,000
0
358,000
0
420,000
524,000
425,000
522,000
403,000
493,000
-2,927,000
-2,927,000493,000403,000522,000425,000524,000420,0000358,0000329,0000165,0000104,0000124,000094,000091,0000700,000093,000052,000066,00064,00085,00070,00075,00064,00065,00069,00069,000255,000248,000237,000233,000252,000208,000
> Total Liabilities 
4,271,000
3,495,000
3,477,000
3,594,000
3,221,000
2,952,000
2,670,000
3,091,000
2,779,000
2,962,000
3,059,000
2,897,000
2,867,000
3,225,000
3,221,000
3,557,000
3,557,000
461,561
3,771,000
4,617,000
4,617,000
5,545,000
5,545,000
6,405,000
6,405,000
6,737,000
6,737,000
0
7,752,000
0
7,150,000
0
7,676,000
0
7,479,000
0
7,893,000
7,272,000
7,272,000
7,620,000
7,620,000
7,130,000
7,130,000
7,130,0007,130,0007,620,0007,620,0007,272,0007,272,0007,893,00007,479,00007,676,00007,150,00007,752,00006,737,0006,737,0006,405,0006,405,0005,545,0005,545,0004,617,0004,617,0003,771,000461,5613,557,0003,557,0003,221,0003,225,0002,867,0002,897,0003,059,0002,962,0002,779,0003,091,0002,670,0002,952,0003,221,0003,594,0003,477,0003,495,0004,271,000
   > Total Current Liabilities 
1,466,000
774,000
1,107,000
2,150,000
1,192,000
1,050,000
985,000
1,382,000
1,290,000
956,000
921,000
869,000
1,014,000
1,164,000
959,000
1,641,000
1,641,000
186,656
1,525,000
2,132,000
2,132,000
1,350,000
1,350,000
2,090,000
2,090,000
1,830,000
1,830,000
2,382,000
2,382,000
1,796,000
1,796,000
2,414,000
2,414,000
2,318,000
2,318,000
2,872,000
2,872,000
1,925,000
1,971,000
2,890,000
2,890,000
2,061,000
2,061,000
2,061,0002,061,0002,890,0002,890,0001,971,0001,925,0002,872,0002,872,0002,318,0002,318,0002,414,0002,414,0001,796,0001,796,0002,382,0002,382,0001,830,0001,830,0002,090,0002,090,0001,350,0001,350,0002,132,0002,132,0001,525,000186,6561,641,0001,641,000959,0001,164,0001,014,000869,000921,000956,0001,290,0001,382,000985,0001,050,0001,192,0002,150,0001,107,000774,0001,466,000
       Short-term Debt 
791,000
42,000
314,000
1,411,000
437,000
333,000
214,000
532,000
420,000
105,000
57,000
112,000
208,000
305,000
7,000
1,649,000
711,000
36,842
308,000
967,000
970,000
0
4,000
0
696,000
291,000
335,000
0
846,000
0
206,000
0
727,000
0
428,000
0
1,140,000
307,000
356,000
1,359,000
1,407,000
397,000
442,000
442,000397,0001,407,0001,359,000356,000307,0001,140,0000428,0000727,0000206,0000846,0000335,000291,000696,00004,0000970,000967,000308,00036,842711,0001,649,0007,000305,000208,000112,00057,000105,000420,000532,000214,000333,000437,0001,411,000314,00042,000791,000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,649,000
1,649,000
36,842
36,695
967,000
967,000
1,000
1,000
652,000
696,000
291,000
293,000
0
806,000
0
161,000
0
672,000
0
380,000
0
1,087,000
0
356,000
0
1,359,000
0
397,000
397,00001,359,0000356,00001,087,0000380,0000672,0000161,0000806,0000293,000291,000696,000652,0001,0001,000967,000967,00036,69536,8421,649,0001,649,000000000000000000
       Accounts payable 
322,000
304,000
344,000
325,000
351,000
340,000
363,000
386,000
419,000
394,000
423,000
392,000
400,000
427,000
494,000
493,000
493,000
81,027
662,000
640,000
640,000
719,000
719,000
835,000
835,000
833,000
833,000
856,000
856,000
809,000
809,000
870,000
870,000
1,008,000
1,008,000
960,000
960,000
861,000
861,000
845,000
845,000
891,000
891,000
891,000891,000845,000845,000861,000861,000960,000960,0001,008,0001,008,000870,000870,000809,000809,000856,000856,000833,000833,000835,000835,000719,000719,000640,000640,000662,00081,027493,000493,000494,000427,000400,000392,000423,000394,000419,000386,000363,000340,000351,000325,000344,000304,000322,000
       Other Current Liabilities 
108,000
98,000
140,000
126,000
153,000
154,000
161,000
188,000
153,000
174,000
155,000
123,000
138,000
138,000
174,000
325,000
168,000
49,326
195,000
398,000
174,000
445,000
225,000
422,000
198,000
470,000
1,495,000
524,000
206,000
564,000
1,590,000
638,000
659,000
642,000
261,000
623,000
772,000
757,000
754,000
686,000
251,000
773,000
592,000
592,000773,000251,000686,000754,000757,000772,000623,000261,000642,000659,000638,0001,590,000564,000206,000524,0001,495,000470,000198,000422,000225,000445,000174,000398,000195,00049,326168,000325,000174,000138,000138,000123,000155,000174,000153,000188,000161,000154,000153,000126,000140,00098,000108,000
   > Long-term Liabilities 
2,805,000
2,721,000
2,370,000
1,444,000
2,029,000
1,902,000
1,685,000
1,709,000
1,489,000
2,006,000
2,138,000
2,028,000
1,853,000
2,061,000
2,262,000
0
1,916,000
0
2,246,000
0
2,485,000
0
4,195,000
0
4,315,000
0
4,907,000
0
5,370,000
0
5,354,000
0
5,262,000
0
5,161,000
0
5,021,000
5,347,000
5,301,000
4,730,000
4,730,000
5,069,000
5,069,000
5,069,0005,069,0004,730,0004,730,0005,301,0005,347,0005,021,00005,161,00005,262,00005,354,00005,370,00004,907,00004,315,00004,195,00002,485,00002,246,00001,916,00002,262,0002,061,0001,853,0002,028,0002,138,0002,006,0001,489,0001,709,0001,685,0001,902,0002,029,0001,444,0002,370,0002,721,0002,805,000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
978,000
978,000
115,788
115,328
830,000
830,000
929,000
929,000
1,062,000
1,062,000
1,111,000
1,111,000
1,153,000
1,153,000
1,109,000
1,109,000
956,000
956,000
922,000
922,000
722,000
722,000
652,000
652,000
0
0
0
0
0000652,000652,000722,000722,000922,000922,000956,000956,0001,109,0001,109,0001,153,0001,153,0001,111,0001,111,0001,062,0001,062,000929,000929,000830,000830,000115,328115,788978,000978,000000000000000000
> Total Stockholder Equity
2,805,000
3,555,000
3,446,000
3,204,000
3,495,000
3,519,000
3,680,000
3,292,000
3,423,000
3,189,000
3,413,000
3,023,000
3,415,000
2,934,000
3,293,000
3,060,000
3,060,000
433,042
3,538,000
3,439,000
3,439,000
3,710,000
3,710,000
3,346,000
3,346,000
3,640,000
3,640,000
0
3,145,000
0
3,490,000
0
3,652,000
0
3,929,000
0
4,016,000
4,232,000
4,232,000
3,941,000
3,941,000
3,993,000
3,993,000
3,993,0003,993,0003,941,0003,941,0004,232,0004,232,0004,016,00003,929,00003,652,00003,490,00003,145,00003,640,0003,640,0003,346,0003,346,0003,710,0003,710,0003,439,0003,439,0003,538,000433,0423,060,0003,060,0003,293,0002,934,0003,415,0003,023,0003,413,0003,189,0003,423,0003,292,0003,680,0003,519,0003,495,0003,204,0003,446,0003,555,0002,805,000
   Common Stock
85,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
11,261
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,000
92,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00011,26192,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00092,00085,000
   Retained Earnings 
3,741,000
4,495,000
4,632,000
4,556,000
4,688,000
4,689,000
4,899,000
4,838,000
5,057,000
4,929,000
5,187,000
5,065,000
5,361,000
5,246,000
5,477,000
5,346,000
5,346,000
695,463
5,682,000
5,519,000
5,519,000
5,811,000
5,811,000
5,639,000
5,639,000
5,961,000
5,961,000
5,803,000
5,803,000
6,133,000
6,133,000
6,025,000
6,025,000
6,365,000
6,365,000
6,198,000
6,198,000
6,442,000
6,614,000
6,446,000
6,446,000
6,730,000
6,730,000
6,730,0006,730,0006,446,0006,446,0006,614,0006,442,0006,198,0006,198,0006,365,0006,365,0006,025,0006,025,0006,133,0006,133,0005,803,0005,803,0005,961,0005,961,0005,639,0005,639,0005,811,0005,811,0005,519,0005,519,0005,682,000695,4635,346,0005,346,0005,477,0005,246,0005,361,0005,065,0005,187,0004,929,0005,057,0004,838,0004,899,0004,689,0004,688,0004,556,0004,632,0004,495,0003,741,000
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000
   Other Stockholders Equity -199,000-199,000-2,597,000-216,000-2,474,000-228,000-2,274,000-2,049,000-2,528,000-2,317,000-2,465,000-2,223,000-2,735,000-2,567,000-2,750,000-2,552,000-2,413,000-2,245,000-2,385,000-2,209,000-2,193,000-2,051,000-2,172,000-2,001,000-2,236,000-254,464-2,378,000-2,201,000-2,276,000-2,404,000-2,038,000-2,134,000-1,866,000-1,832,000-1,726,000-1,638,000-1,311,000-1,262,000-1,285,000-1,444,000-1,278,000-1,032,000-1,021,000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.